136 related articles for article (PubMed ID: 37883729)
1. Plasma Methylated DNA Markers for Melanoma Surveillance.
Berger CK; Taylor WR; Mahoney DW; Burger KN; Doering KA; Gonser AM; Cao X; Heilberger J; Gysbers BJ; Foote PH; Kottschade LA; Markovic SN; Lehman JS; Katerov VE; Allawi HT; Kisiel JB; Meves A
JCO Precis Oncol; 2023 Sep; 7():e2300389. PubMed ID: 37883729
[TBL] [Abstract][Full Text] [Related]
2. Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility.
Marinelli LM; Kisiel JB; Slettedahl SW; Mahoney DW; Lemens MA; Shridhar V; Taylor WR; Staub JK; Cao X; Foote PH; Burger KN; Berger CK; O'Connell MC; Doering KA; Giakoumopoulos M; Berg H; Volkmann C; Solsrud A; Allawi HT; Kaiser M; Vaccaro AM; Albright Crawford C; Moehlenkamp C; Shea G; Deist MS; Schoolmeester JK; Kerr SE; Sherman ME; Bakkum-Gamez JN
Gynecol Oncol; 2022 Jun; 165(3):568-576. PubMed ID: 35370009
[TBL] [Abstract][Full Text] [Related]
3. Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence.
Xie H; Mahoney DW; Foote PH; Burger KN; Doering KA; Taylor WR; Then SS; Cao X; McGlinch M; Berger CK; Wu TT; Hubbard JM; Allawi HT; Kaiser MW; Lidgard GP; Ahlquist DA; Kisiel JB
Clin Cancer Res; 2021 Jan; 27(1):141-149. PubMed ID: 33028593
[TBL] [Abstract][Full Text] [Related]
4. Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma.
Qin Y; Wu CW; Taylor WR; Sawas T; Burger KN; Mahoney DW; Sun Z; Yab TC; Lidgard GP; Allawi HT; Buttar NS; Smyrk TC; Iyer PG; Katzka DA; Ahlquist DA; Kisiel JB
Clin Cancer Res; 2019 Dec; 25(24):7396-7404. PubMed ID: 31527170
[TBL] [Abstract][Full Text] [Related]
5. Detection of endometrial cancer using tampon-based collection and methylated DNA markers.
Bakkum-Gamez JN; Sherman ME; Slettedahl SW; Mahoney DW; Lemens MA; Laughlin-Tommaso SK; Hopkins MR; VanOosten A; Shridhar V; Staub JK; Cao X; Foote PH; Clarke MA; Burger KN; Berger CK; O'Connell MC; Doering KA; Podratz KC; DeStephano CC; Schoolmeester JK; Kerr SE; Wentzensen N; Taylor WR; Kisiel JB
Gynecol Oncol; 2023 Jul; 174():11-20. PubMed ID: 37141817
[TBL] [Abstract][Full Text] [Related]
6. High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9.
Majumder S; Taylor WR; Foote PH; Berger CK; Wu CW; Mahoney DW; Bamlet WR; Burger KN; Postier N; de la Fuente J; Doering KA; Lidgard GP; Allawi HT; Petersen GM; Chari ST; Ahlquist DA; Kisiel JB
Clin Cancer Res; 2021 May; 27(9):2523-2532. PubMed ID: 33593879
[TBL] [Abstract][Full Text] [Related]
7. Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma.
Anderson BW; Suh YS; Choi B; Lee HJ; Yab TC; Taylor WR; Dukek BA; Berger CK; Cao X; Foote PH; Devens ME; Boardman LA; Kisiel JB; Mahoney DW; Slettedahl SW; Allawi HT; Lidgard GP; Smyrk TC; Yang HK; Ahlquist DA
Clin Cancer Res; 2018 Nov; 24(22):5724-5734. PubMed ID: 29844130
[No Abstract] [Full Text] [Related]
8. Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation.
Kisiel JB; Dukek BA; V S R Kanipakam R; Ghoz HM; Yab TC; Berger CK; Taylor WR; Foote PH; Giama NH; Onyirioha K; Abdallah MA; Burger KN; Slettedahl SW; Mahoney DW; Smyrk TC; Lewis JT; Giakoumopoulos M; Allawi HT; Lidgard GP; Roberts LR; Ahlquist DA
Hepatology; 2019 Mar; 69(3):1180-1192. PubMed ID: 30168613
[TBL] [Abstract][Full Text] [Related]
9. DNA Methylation Markers for Detection of Cholangiocarcinoma: Discovery, Validation, and Clinical Testing in Biliary Brushings and Plasma.
Yang JD; Ghoz H; Aboelsoud MM; Taylor WR; Yab TC; Berger CK; Cao X; Foote PH; Giama NH; Barr Fritcher EG; Mahoney DW; Moser CD; Smyrk TC; Kipp BR; Gores GJ; Roberts LR; Kisiel JB
Hepatol Commun; 2021 Aug; 5(8):1448-1459. PubMed ID: 34430788
[TBL] [Abstract][Full Text] [Related]
10. Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing.
Majumder S; Taylor WR; Yab TC; Berger CK; Dukek BA; Cao X; Foote PH; Wu CW; Mahoney DW; Aslanian HR; Fernández-Del Castillo C; Doyle LA; Farrell JJ; Fisher WE; Lee LS; Lee YN; Park W; Rodrigues C; Gould Rothberg BE; Salem RR; Simeone DM; Urs S; Van Buren G; Smyrk TC; Allawi HT; Lidgard GP; Raimondo M; Chari ST; Kendrick ML; Kisiel JB; Topazian MD; Ahlquist DA
Am J Gastroenterol; 2019 Sep; 114(9):1539-1549. PubMed ID: 31306149
[TBL] [Abstract][Full Text] [Related]
11. Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease.
Bartemes KR; Gochanour BR; Routman DM; Ma DJ; Doering KA; Burger KN; Foote PH; Taylor WR; Mahoney DW; Berger CK; Cao X; Then SS; Haller TJ; Larish AM; Moore EJ; Garcia JJ; Graham RP; Bakkum-Gamez JN; Kisiel JB; Van Abel KM
Oral Oncol; 2023 Nov; 146():106568. PubMed ID: 37717549
[TBL] [Abstract][Full Text] [Related]
12. Methylated DNA in Pancreatic Juice Distinguishes Patients With Pancreatic Cancer From Controls.
Majumder S; Raimondo M; Taylor WR; Yab TC; Berger CK; Dukek BA; Cao X; Foote PH; Wu CW; Devens ME; Mahoney DW; Smyrk TC; Pannala R; Chari ST; Vege SS; Topazian MD; Petersen BT; Levy MJ; Rajan E; Gleeson FC; Abu Dayyeh B; Nguyen CC; Faigel DO; Woodward TA; Wallace MB; Petersen G; Allawi HT; Lidgard GP; Kisiel JB; Ahlquist DA
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):676-683.e3. PubMed ID: 31323382
[TBL] [Abstract][Full Text] [Related]
13. Methylated tissue factor pathway inhibitor 2 (TFPI2) DNA in serum is a biomarker of metastatic melanoma.
Lo Nigro C; Wang H; McHugh A; Lattanzio L; Matin R; Harwood C; Syed N; Hatzimichael E; Briasoulis E; Merlano M; Evans A; Thompson A; Leigh I; Fleming C; Inman GJ; Proby C; Crook T
J Invest Dermatol; 2013 May; 133(5):1278-85. PubMed ID: 23407390
[TBL] [Abstract][Full Text] [Related]
14. Highly Discriminant Methylated DNA Markers for the Non-endoscopic Detection of Barrett's Esophagus.
Iyer PG; Taylor WR; Johnson ML; Lansing RL; Maixner KA; Yab TC; Simonson JA; Devens ME; Slettedahl SW; Mahoney DW; Berger CK; Foote PH; Smyrk TC; Wang KK; Wolfsen HC; Ahlquist DA
Am J Gastroenterol; 2018 Aug; 113(8):1156-1166. PubMed ID: 29891853
[TBL] [Abstract][Full Text] [Related]
15. Methylated DNA Markers of Esophageal Squamous Cancer and Dysplasia: An International Study.
Qin Y; Taylor W; Bamlet WR; Ravindran A; Buglioni A; Cao X; Foote PH; Slettedahl SW; Mahoney DW; Albert PS; Kim S; Hu N; Taylor PR; Etemadi A; Sotoudeh M; Malekzadeh R; Abnet CC; Smyrk TC; Katzka D; Topazian MD; Dawsey SM; Ahlquist D; Kisiel JB; Iyer PG
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2642-2650. PubMed ID: 32948633
[TBL] [Abstract][Full Text] [Related]
16. Accurate Nonendoscopic Detection of Barrett's Esophagus by Methylated DNA Markers: A Multisite Case Control Study.
Iyer PG; Taylor WR; Johnson ML; Lansing RL; Maixner KA; Hemminger LL; Cayer FK; Yab TC; Devens ME; Slettedahl SW; Broderick BT; Mahoney DW; McGlinch MC; Berger CK; Foote PH; Giakomopoulos M; Allawi H; Smyrk TC; Wang KK; Katzka DA; Wolfsen HC; Burke JA; Ahlquist DA; Kisiel JB
Am J Gastroenterol; 2020 Aug; 115(8):1201-1209. PubMed ID: 32558685
[TBL] [Abstract][Full Text] [Related]
17. Benign nodal nevi frequently harbor the activating V600E BRAF mutation.
Taube JM; Begum S; Shi C; Eshleman JR; Westra WH
Am J Surg Pathol; 2009 Apr; 33(4):568-71. PubMed ID: 19033861
[TBL] [Abstract][Full Text] [Related]
18. Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype.
Albrecht LJ; Höwner A; Griewank K; Lueong SS; von Neuhoff N; Horn PA; Sucker A; Paschen A; Livingstone E; Ugurel S; Zimmer L; Horn S; Siveke JT; Schadendorf D; Váraljai R; Roesch A
Clin Transl Med; 2022 Nov; 12(11):e1090. PubMed ID: 36320118
[TBL] [Abstract][Full Text] [Related]
19. Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report.
Mordoh A; Triviño Pardo JC; Carri I; Barrio MM; Mordoh J; Aris M
BMC Med Genomics; 2023 Jan; 16(1):1. PubMed ID: 36604730
[TBL] [Abstract][Full Text] [Related]
20. Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy.
Gao L; van den Hurk K; Moerkerk PTM; Goeman JJ; Beck S; Gruis NA; van den Oord JJ; Winnepenninckx VJ; van Engeland M; van Doorn R
J Invest Dermatol; 2014 Dec; 134(12):2957-2966. PubMed ID: 24999589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
